Symbotic closed the week at $44.95, up 17% in five sessions — yet short interest climbed in near-lockstep, rising 10.5% over the same period to 14.5% of the free float. That tension between price and positioning is the story heading into the company's July 27 earnings.
Short interest at 14.5% of float is elevated, and the direction of travel sharpens the picture. Bears added roughly 1.6 million shares to their positions over the past month, pushing the total above 16.4 million shares. The ORTEX short score has drifted up to 71.4, its highest reading in the tracked history, and the days-to-cover sits at 7.2 per the latest FINRA data — meaning shorts would need more than a week of average volume to unwind. Against that, the borrow market remains unusually relaxed. Availability runs near 196%, meaning roughly two shares are available to lend for every one already borrowed. Cost to borrow is just 0.58%, barely moved despite the rise in short positions. The borrow market is not signalling stress — shorts can add freely, and there is no mechanical squeeze pressure at current levels. Options traders have also shifted to the bullish side: the put/call ratio has dropped to 0.51, more than one standard deviation below its 20-day average of 0.56, and close to the 52-week low of 0.46. Call positioning has clearly picked up alongside the price move.
The Street is split in a way that reflects the stock's unusual risk profile. The consensus is a formal Hold, with six analysts in that camp and a mean price target around $65 — implying roughly 45% upside from current levels. Goldman Sachs is the most visible bear, carrying a Sell with a $45 target that it lowered from $54 in late May. At current prices, SYM is essentially trading at Goldman's bear-case number. On the other side, DA Davidson and Needham both hold Buy ratings with targets at $70–$75, and Keybanc initiated at Overweight earlier in the year with a $70 target. The bull case centres on strong forward earnings growth — the 12-month forward EPS year-on-year increase ranks in the 98th percentile of the broader universe — and management guidance pointing to positive GAAP net income this year. The bear case is structural: Walmart accounts for 87% of revenue and holds 13% equity, making SYM less a diversified automation platform and more a single-contract execution story. The EV/EBITDA multiple at roughly 10x is not demanding for a high-growth industrial tech name, but the price-to-book of nearly 24x leaves little room for execution slippage.
Ownership adds one notable data point. SoftBank, the largest shareholder at 31% of shares outstanding, sold 5.59 million shares on May 27 for roughly $282 million — a significant block. Individual director-level sells in early June were immaterial in size, low single-digit significance scores. The net insider position over 90 days is technically positive in share terms, but that reflects non-cash equity awards; the actual cash selling has been consistent and one-directional. Baillie Gifford holds 9.8% and added a small position in Q1; Vanguard established new holdings in the same period. The institutional base is broadening slightly at the margin, even as the two largest strategic holders — SoftBank and Walmart — sit unchanged or trimming.
The historical reaction pattern at earnings is short and consistent: SYM fell 2.8% the day after its May 2026 print, and a further 14% over the following five sessions. The prior quarter produced a similar pattern: down 1.4% on the day, down 12% over the following week. With shorts rebuilding into a strong rally, call positioning elevated, and July 27 earnings approaching, the next print is less about whether automation demand is growing and more about whether Walmart deployment timelines and any progress on customer diversification can shift the bear narrative that has persisted since the Goldman downgrade.
See the live data behind this article on ORTEX.
Open SYM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
